Registry of patients in preventive cardiology clinics
Official title: Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention
Run by National Institute of Cardiovascular Diseases, Pakistan · NCT06503341 · Data updated 2026-11-12
This study is creating a registry of patients visiting preventive cardiology clinics to see how well we can identify heart health risks and work together on treatment plans.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | National Institute of Cardiovascular Diseases, Pakistan Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Status | Recruiting |
| Started | June 17, 2021 |
| Main results expected | June 1, 2031 |
| Study ends | June 1, 2041 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06503341 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals attending preventive cardiology clinics seeking cardiovascular risk assessment.
✕Probably not a fit
Patients who refuse to give consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a registry of patients attending preventive cardiology clinics at the National Institute of Cardiovascular Diseases in Karachi, Pakistan. It focuses on assessing cardiovascular risk factors and developing effective treatment plans through shared decision-making between clinicians and patients. Data will be collected on demographic characteristics, clinical history, and risk assessments, with follow-ups to monitor outcomes. The study will utilize statistical analysis to evaluate the collected data and contribute to research publications.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of cardiovascular risk factors and improve preventive strategies for cardiovascular disease.
How similar studies have gone: Other studies have shown success in using registries for cardiovascular risk assessment, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All individuals attending the preventive cardiology clinics. Exclusion Criteria: * • Individuals who refused to give consent.
Where it's running
-
National Institute of Cardiovascular Diseases
Karachi, Sindh, Pakistan Recruiting
Study contacts
- Principal investigator: Dr Rubina Rauf — National Institute of Cardiovascular Diseases
- Study coordinator: Dr Rubina Rauf
- Email: drrubinarauf@gmail.com
- Phone: +923002947117
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diagnosing brief stroke-like (TIA) events in the emergency room
This project will look at how adults who come to the emergency room with a transient ischemic attack (TIA) are managed to see if extra tests, treatments, and referrals match their cardiovascular risk.
-
Investigating arterial stiffening's role in heart failure with preserved ejection fraction
This study is trying to see if measuring how stiff the arteries are can help identify people at risk for developing heart failure with preserved ejection fraction.
-
Raising gut Akkermansia muciniphila with oral acetate (apple cider vinegar) during androgen deprivation therapy
This tests whether taking oral acetate (apple cider vinegar) can raise Akkermansia muciniphila levels in the gut and help metabolic and bone health in men starting androgen deprivation therapy for metastatic castration‑sensitive prostate cancer.
-
Effects of metabolic health patterns on breast cancer outcomes in women
This study is testing whether improving metabolic health through diet and activity changes can help women with breast cancer feel better and reduce their heart disease risk during and after chemotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.